chartexchange

IBRX280121P00022000
IBRX Jan 21 2028 22.00 Put
optionOPRA

EODOct 16, 2026
13.23USD+0.838%(+0.11)5Vol56OI
Loading…
Underlying
Underlying Price
$8.48
Type
Put
Strike
22
Expiration
Jan 21, 2028
DTE
458d
Moneyness
ITM
Intrinsic
$13.52
IBRX 22 Put Across Expirations
ExpirationDTELastChangeVolOpen Int
Jan 15, 202787d$11.97-9.32%3143
Jan 21, 2028458d$13.23+0.84%556
IBRX Nearby Strikes · Jan 21, 2028
StrikeLastChangeVolOpen IntMoneyness
7.5 P$1.95-9.30%1259,702OTM
10 P$3.50+3.24%503,806ITM
12 P$4.98-4.23%1042ITM
15 P$7.25-14.71%1676ITM
17 P$8.75-1.02%58ITM
20 P$14.10+6.82%237ITM
22 P$13.23+0.84%556ITM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.